Sara Nayeem
SaraNayeem
Thread: advice for preclinical biotechs on their in vivo datasets. For preclinical biotechs seeking funding, the difference between a vaguely interesting data set & a fundable data set often comes
Read more
Nice article from @sheridan_kate of @statnews on the weird intricacies of biopharma valuations. I also think we've been in an environment where clinical stage co's are often valued lower than
Read more
I am haunted by the video of #GeorgeFloyd's brutal, callous murder - a subdued man slowly executed by someone sworn to serve and protect. It echoes so many other videos
Read more